Aarti Drugs quarterly profit rises about 61% as Sayakha plant starts

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹487.10

prior close

₹484.00

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.4%+0.5% vs market

Pharmaceuticals peers, median of 156sector-0.1%+1.0% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.4

10m

+1.1

15m

+0.6

30m

+2.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+0.4+0.5-0.1+1.0

Next day

+6.7+0.0+6.6-0.7+7.3

-2.3-0.2-2.0-0.9-1.4

-2.3+0.7-3.0+0.1-2.5

-3.7+0.6-4.3+0.2-4.0

-4.5+0.5-5.1+0.0-4.5

-7.5+0.3-7.8-0.3-7.2

15d

-12.7-1.5-11.3-1.6-11.1

-18.3-6.6-11.7-5.3-13.0

-17.3-3.2-14.1-2.8-14.6

-22.7-5.2-17.5-7.3-15.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aarti Drugs approved audited company-only and combined group results for the quarter and half-year ended September 30, 2025. Combined quarterly net profit rose about 61% to Rs 109.69 crore from Rs 68.23 crore, while revenue grew by more than 20% from a year earlier. The Sayakha plant started commercial production on September 4. A gas leak affected one unit, which was expected to continue normal operations. The audit report was clean.

Likely market impact

Strong growth and wider margins may support the stock. The new plant adds capacity, but investors should watch its ramp-up after the gas leak.